Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 8/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CD40 | P25942 | 1/20 | 0.33 |
| ▸ | CD40LG | P29965 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.32 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.32 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.32 |
| ▸ | EP300 | Q09472 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13949157 | 0.91 | FUT8 (0.41) | ENPP2MEN1THRBKMT2ACD40 | |
| SCHEMBL13949168 | 0.85 | FUT8 (0.41) | ENPP2MEN1THRBKMT2AFUT8 | |
| SCHEMBL13949175 | 0.84 | THRB (0.35) | ENPP2THRBFUT8CYP1A2 | |
| SCHEMBL13538879 | 0.83 | FUT8 (0.53) | ENPP2MEN1THRBKMT2ATDP1 | |
| SCHEMBL13387197 | 0.81 | FUT8 (0.46) | ENPP2MEN1THRBKMT2ACD40 | |
| SCHEMBL13880626 | 0.81 | FUT8 (0.50) | ENPP2MEN1THRBKMT2ACD40 | |
| SCHEMBL14565547 | 0.81 | FUT8 (0.50) | ENPP2MEN1THRBKMT2ACD40 | |
| SCHEMBL13387299 | 0.79 | FUT8 (0.43) | ENPP2MEN1THRBKMT2ACD40 | |
| SCHEMBL14372027 | 0.79 | FUT8 (0.49) | ENPP2MEN1THRBKMT2ATDP1 | |
| SCHEMBL13949183 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090018317-A1 | Reactive dyestuffs with alkylthio group and beta-sulfatoethysulfone group | EVERLIGHT USA, INC. (US) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018317-A1 | Reactive dyestuffs with alkylthio group and beta-sulfatoethysulfone group | PADI1, PADI2, PADI4 | ENPP2 3807/4885MEN1 4644/4885THRB 2600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.